61062-56-4 Usage
General Description
2-Amino-3'-trifluoromethylacetophenone hydrochloride is a chemical compound that is commonly used in research and development. It is a derivative of acetophenone and contains a trifluoromethyl group, making it a valuable tool for the synthesis of pharmaceuticals and other organic compounds. 2-AMINO-3'-TRIFLUOROMETHYLACETOPHENONE HYDROCHLORIDE can be utilized as a building block in the preparation of various biologically active molecules and is often used as a reagent in chemical reactions. Its hydrochloride salt form increases its solubility in water, making it easier to handle and manipulate in laboratory settings. Overall, 2-amino-3'-trifluoromethylacetophenone hydrochloride is a versatile chemical that plays a significant role in the field of organic synthesis and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 61062-56-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,0,6 and 2 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 61062-56:
(7*6)+(6*1)+(5*0)+(4*6)+(3*2)+(2*5)+(1*6)=94
94 % 10 = 4
So 61062-56-4 is a valid CAS Registry Number.
61062-56-4Relevant articles and documents
N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-CARBOXAMIDE DERIVATIVES AND THE CORRESPONDING OXADIAZOLE DERIVATIVES AS USP30 INHIBITORS FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION
-
, (2021/12/08)
The present invention relates to a class of N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibros
Rapid development and scale-up of a 1 H -4-substituted imidazole intermediate enabled by chemistry in continuous plug flow reactors
May, Scott A.,Johnson, Martin D.,Braden, Timothy M.,Calvin, Joel R.,Haeberle, Brian D.,Jines, Amy R.,Miller, Richard D.,Plocharczyk, Edward F.,Rener, Gregory A.,Richey, Rachel N.,Schmid, Christopher R.,Vaid, Radhe K.,Yu, Hannah
, p. 982 - 1002 (2012/08/27)
The development of reactions in a continuous fashion in plug flow tube reactors (PFR) offers unique advantages to the drug development and scale-up process and can also enable chemistry that would be difficult to perform via batch processing. Herein, we r
